Fortunato Ciardiello - Researcher Profile

Publications

3 shown

Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells

Roberto Bianco , Roberta Rosa , Vincenzo Damiano +11 more

Abstract Purpose: The resistance to selective EGFR inhibitors involves the activation of alternative signaling pathways, and Akt activation and VEGF induction have been describe...

2008 Clinical Cancer Research 143 citations

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Achim Rittmeyer , Fabrice Barlési , Daniel Waterkamp +22 more

2016 The Lancet 4635 citations

Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer

Scott Kopetz , Axel Grothey , Rona Yaeger +32 more

A combination of encorafenib, cetuximab, and binimetinib resulted in significantly longer overall survival and a higher response rate than standard therapy in patients with meta...

2019 New England Journal of Medicine 1353 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 6,131
Institution: University of Naples Federico II

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-3369-4841

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.